BioPharma Drug Discovery

Esco Aster Provides CMC Manufacturing Support For Shine On Biomedical’s HLA G Targeted Exosome Program

Esco Aster, a vertically integrated cell and derivatives CRDMO based at JTC LaunchPad Singapore, announced CMC manufacturing support for Shine-On Biomedica...

 December 17, 2025 | News

Pixelgen Expands Asia Pacific Footprint With South Korea Distribution Agreement

- Pixelgen Technologies, Inc. and MDxK (Molecular Diagnostics Korea) Inc., part of DKSH Business Unit Technology, a leader in market expansion se...

 December 16, 2025 | News

Insilico Medicine Partners with TaiGen to Accelerate AI-Driven Anemia Therapy in Greater China

Insilico Medicine has licensed TaiGen Biotechnology exclusive rights in the Greater China area to develop, commercialize, and sub-license ISM48...

 December 15, 2025 | News

Sanyou Bio and KanryBio Form Strategic Partnership to Co-Develop Biomarker Assay Kits

Sanyou Biopharmaceuticals (Shanghai) Co., Ltd. ("Sanyou Bio") and Wenzhou KanryBio Biotech Co., Ltd.  ("KanryBio") announced a strategi...

 December 15, 2025 | News

Formation Bio Acquires Global Rights To CNS Penetrant TYK2 Inhibitor LNK01006

Lynk Pharmaceuticals Co., Ltd. (hereinafter referred to as "Lynk Pharmaceuticals") and Formation Bio announced Formation Bio's acquisition of wor...

 December 11, 2025 | News

Bora Pharmaceuticals Forms Strategic Alliance with Corealis Pharma to Streamline Drug Development

Partnership creates simplified pathway from early development to commercial launch Bora Pharmaceuticals Co., Ltd. ("Bora", TWSE: 6472), a global leader ...

 December 10, 2025 | News

Innovent Biologics Seven Innovative Therapies Included in China’s 2025 National Reimbursement Drug List

 Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high qual...

 December 08, 2025 | News

Mango Sciences Partners with ImmunoACT to Expand Access to NexCAR19 CAR-T Therapy in India

Mango Sciences, Inc., the Boston, US, and Bengaluru, IN-based data and AI company, announced a strategic partnership with ImmunoAdoptive Cell Therapy (Immu...

 December 08, 2025 | News

Biocytogen Announces FDA IND Clearance for IDE034 Bispecific B7H3 PTK7 ADC Licensed to IDEAYA Biosciences

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, HKEX: 02315), announced that its partner IDEAYA Biosciences, Inc. (Nasdaq: IDYA), a precision o...

 December 08, 2025 | News

Kelun Biotech And Crescent Biopharma Forge Global Partnership To Advance Next Generation Oncology Therapies

Companies to advance CR-001, a PD-1 x VEGF bispecific antibody, and SKB105, an integrin beta-6-directed antibody-drug conjugate (ADC), in global markets an...

 December 05, 2025 | News

Formosa Pharmaceuticals Grants Exclusive ASEAN Rights For APP13007 To Rxilient Medical

Taiwan-based Formosa Pharmaceuticals ("Formosa", 6838.TW) announced  that the company has entered into an exclusive licensing agreement with Rxil...

 December 04, 2025 | News

Antengene Secures Expanded Approvals For Xpovio In Hong Kong Across Multiple Myeloma And DLBCL

- XPOVIO® (selinexor) has received approvals for three indications in Hong Kong. These include its previous approval as the treatment for mul...

 December 04, 2025 | News

AGC Biologics Strengthens Global Cell Line Capabilities With ATUM Partnership and Leap In Technology

New offering provides drug developers with flexible and powerful cell line development options for monoclonal antibodies, multi-specific and complex mole...

 December 04, 2025 | News

Samsung Bioepis Gains CHMP Backing for BYOOVIZ Pre Filled Syringe

European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) adopts positive opinion for BYOOVIZ® (ranibizuma...

 December 03, 2025 | News


News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close